The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Diabetes mellitus in percutaneous coronary intervention: greater awareness is needed to predict and prevent poor outcomes

EuroIntervention 2014;10:13-15. DOI: 10.4244/EIJV10I1A2

Department of Cardiology, Cardiac Renal Centre, Cork University Hospital, Wilton, Cork, Ireland
Diabetes is recognised as one of the most important global health threats today. In 2011, an estimated 52 million Europeans were diabetic, a figure that is steadily increasing. As many of them are asymptomatic, only half are diagnosed. The incidence rises with age and the lifetime risk of developing diabetes in Europe is 30-40%. The great majority, over 90% of cases, have type 2 diabetes caused by a combination of insulin resistance and failing beta cell function1. A glycaemic continuum is recognised, whereby progressively abnormal glucometabolic regulation is associated with decreased insulin sensitivity, hyperinsulinaemia and rising glucose levels until thresholds for a diagnosis of ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
The balance of bleeding and ischaemic events in surgical patients after stenting